期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

MODS患者连续性血滤过程中血小板的变化 被引量：2

下载PDF
导出
摘要 目的探讨MODS患者连续性静脉-静脉血滤(CVVH)过程中血小板计数(Plt)的变化及其临床意义。方法回顾性分析ICU27例MODS患者CVVH过程中Plt的变化。结果 MODS患者血小板减少症罹患率为51.9%;在48h内,CVVH过程中血小板减少症罹患率明显上升(P<0.05),Plt水平进行性下降(P<0.01),死亡组PltPlt水平下降明显(P<0.05),而生存组变化差异无显著性(P>0.05);于治疗后48h,死亡组Plt水平明显低于生存组(P<0.05);两种稀释法患者在各对应时段Plt水平差异无显著性(P>0.05)。结论血小板减少症通常存在于MODS患者中;CVVH48h内患者Plt水平呈进行性下降,病情恶化是其主要原因;第48小时的Plt水平可作为判断MODS患者预后的指标。
作者 罗辉遇 谢长江 古英明 熊旭明
机构地区 广州医学院第二附属医院老年病科 广州医学院第二附属医院ICU 广州医学院第二附属医院血液净化中心
出处 《广东医学》 CAS CSCD 北大核心 2010年第11期1421-1422,共2页 Guangdong Medical Journal
基金 广东省广州市医药卫生科技项目(编号:2007-YB-162)
关键词 多器官功能不全综合征 血小板计数 连续性静脉-静脉血液滤过
分类号 R446.113 [医药卫生—诊断学]
  • 相关文献

参考文献7

  • 1BALCI C,SUNGURTEKIN H,GURSES E,et al.APACHE II,APACHE III,SOFA scoring systems,platelet counts and mortality in septic and nonseptic patients[J].Ulus Travma Acil Cerrahi Derg,2005,11(1):29-34.
  • 2OGURA H,GANDO S,IBA T,et al.SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia[J].Shock,2007,28(4):411-417.
  • 3高伟,王增智,刘双,肖利.APACHE Ⅱ,SOFA评分和血小板计数对高龄MODS患者预后的研究[J].北京医学,2007,29(8):479-480. 被引量：8
  • 4俞森洋.SIRS、sepsis、严重sepsis和MODS的诊断标准[J].临床肺科杂志,2009,14(1):1-2. 被引量：82
  • 5KEEGAN S P,GALLAGHER E M,ERNST N E,et al.Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia[J].Ann Pharmacother,2009,43(1):19-27.
  • 6NAPOLITANO L M,WARKENTIN T E,ALMAHAMEED A,et al.Heparin-induced thrombocytopenia in the critical care setting:diagnosis and management[J].Crit Care Med,2006,34(12):2898-2911.
  • 7NGUYEN T C,HAN Y Y,KISS J E,et al.Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure[J].Crit Care Med,2008,36(10):2878-2887.

二级参考文献13

  • 1王今达,王宝恩.多脏器功能失常综合征（MODS）病情分期诊断及严重程度评分标准（经庐山’95全国危重病急救医学学术会讨论通过）[J].中国危重病急救医学,1995,7(6):346-347. 被引量：1424
  • 21087例多器官功能障碍综合征临床流行病学调查[J].中国危重病急救医学,2007,19(1):2-6. 被引量：97
  • 3Dellinger RP,levy MM, Carlet JM, et al. Surviving sepsis campaign : international guidelines for management of severe sepsis and septic shock :2008. Crit Care Med ,2008,36 ( 1 ) :296 - 327.
  • 4Knaus WA,Draper EA,Wagner DP,et al.An evaluation of outcome from intensive care in major medical centers.Ann intern Med,1986,104:410-418.
  • 5Vincent JL,Moreno R,Takala J,et al.The SOFA (sepsis related organ failure assessment) score to describe organ dysfunction/failure.Intensive.Care Med,1996,22:707-710.
  • 6Balci C,Sungurtekin H,Gurses E,et al.APACHE Ⅱ,APACHE Ⅲ,SOFA scoring systems,PLT and mortality in septic and nonseptic patients.Ulus Travma Acil Cerrahi Derg,2005,11:29 -34.
  • 7Mereno R,Vincent JL,Matos R,et al.The use of maximum SOFA score to quantify organ dysfunction failure in intensive care,result sofa prospective,multi-centre study.Intensive Care Med,1999,25:686-696.
  • 8Vanderschueren S,Weerdt A,Malbrain M,et al.Thromcytopenia and prognosis in intensive care.Crit Care Med,2000,28:1871 -1876.
  • 9Akca S,Haji-Michael P,de Mendonce A,et al.The time course of PLT in critically ill patients Crit Care Med,2002,30:753 -766.
  • 10Stephan F,Hollande J,Richard O,et al.Thrombocytopenia in asurgical ICU.Chest,1999,115:1363-1370.

共引文献87

同被引文献18

  • 1罗辉遇,谢长江,刘卫江,温德良,张振辉,熊旭明,陈晓辉.重症患者手术前后血浆PT、aPTT、PLT、Ca^(2+)变化的意义[J].血栓与止血学,2006,12(3):120-122. 被引量：4
  • 2Park SY, Lee CY, Kim C, et al. One - year prognosis and the role of brain natriuretic peptide levels in patients with chronic car pulmonale[J]. J Korean Med Sci, 2015, 30(4) : 442 -449.
  • 3Polosa R, Malerba M, Cacciola RR, et al. Effect of acute exacer- bations on circulating endothelial, clotting and fibrinolytic markers in COPD patients[J]. Intern Emerg Med, 2013, 8(7) : 567 - 574.
  • 4Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014[EB/OL]. (2014-01 -01)[2015-06-18]. http: //www. goldcopd, org/.
  • 5Shi XS, Li H. Anticoagulation therapy in patients with chronic ob- structive pulmonary disease in the acute exacerbation stage [ J ]. Exp Ther Med, 2013, 5(5) : 1367 -1370.
  • 6Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and meta a- nalysis[J]. Chest, 2009, 135(3): 786-793.
  • 7van der Poll T, Levi M. Crosstalk between inflammation and coag- ulation : the lessons of sepsis[ J]. Curr Vasc Pharmacol, 2012, 10 (5) : 632 -638.
  • 8Hamad OA, Back J, Nilsson PH, et al. Platelets, complement, and contact activation: partners in inflammation and thrombosis [J]. Adv Exp Med Biol, 2012, 946:185 -205.
  • 9Campo G, Pavasini R, Malagu M, et al. Chronic obstructive pul- monary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management[J]. Cardiovasc Drugs T- her, 2015, 29(2) : 147 -157.
  • 10Williams MC, Murchison JT, Edwards LD, et al. Chronic artery calcification is increased in patients with COPD and associated with increased morbidity and mortality [ J]. Thorax, 2014, 69 ( 8 ) : 718 -723.

引证文献2

二级引证文献9

广东医学
2010年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部